Q2 2025 Management View CEO Joseph J. Ciaffoni reported record SUBLOCADE net revenue, led by solid U.S. performance, stating ...

As of Friday, Aug. 1, the moon phase is First Quarter. This phase occurs when the moon is half lit up. NASA confirms this, ...

NMDOT said the design for phases 1 and 2 is expected to be completed by the end of 2026. The plan is to start construction in ...

(NASDAQ:MRNA) today reported financial results and provided business updates for the second quarter of 2025. "In the last three months, we advanced our pipeline with positive Phase 3 flu vaccine ...

A phase 3 trial of Spine BioPharma’s chronic low back pain candidate has missed its primary endpoint. But, with the biotech pinning the failure on a “very high sham control response,” management plans ...

If you’re driving around Michiana, here are a few new road closures and restrictions you’ll want to know about.

All candidates admitted in Round 1 and Round 2 can opt for seat upgradation based on their higher preferences.

GSK signed a 12-asset licensing deal with Hengrui Pharma. Generic erosion on Vyvanse continued to hurt Takeda. Celltrion is ...

As America’s #1 provider of 3-phase string inverters, CPS America is proud to showcase the latest innovations in solar and ...

TransAlta Corporation ( NYSE: TAC) Q2 2025 Earnings Conference Call August 1, 2025 11:00 AM ET Joel E. Hunter - Executive VP of Finance & CFO John Harry Kousinioris - President, CEO & Director ...

Updated cash guidance provides runway into at least the middle of calendar 2026 Company remains encouraged by MDNA11 clinical results presented to-date, demonstrating best-in-class potential of our IL ...

Ocugen has scheduled a conference call and webcast for 8:30 a.m. ET today to discuss the financial results and recent business highlights. Ocugen’s executive leadership team will host the call, which ...